Evaluation of spot urine albumin creatinine ratio as a screening tool for prediction of preeclampsia
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20253517Keywords:
UACR, Preeclampsia, Spot urine albumin creatinine ratioAbstract
Background: Preeclampsia is the second leading cause of maternal mortality, accounting for approximately 12-18% of pregnancy-related deaths. Spot urine albumin creatinine ratio (UACR) underscores its significance as a practical tool for earlier detection and effective management thereby enhancing clinical outcomes for both mother and their infants.
Methods: Singleton pregnant women between 16 and 20 weeks of gestation attending the antenatal care (ANC) outpatient department (OPD) of GMC Akola were enrolled in this prospective study. The spot urinary albumin-to-creatinine ratio (UACR) was calculated for each case. All patients were placed under regular follow-up at 24 weeks, 28 weeks, 32 weeks, 34 weeks, 36 weeks, and subsequently on a weekly basis until delivery. Special attention was given to identifying the development of preeclampsia during the antenatal period and/or at the time of delivery.
Results: A UACR cutoff of 35.5 mg/mmol was identified as predictive of preeclampsia, with a significant association noted (p<0.0001). Diagnostic performance measures revealed a sensitivity of 85.1%, specificity of 91.4%, PPV of 82.6%, and NPV of 92.8%, suggesting high diagnostic accuracy.
Conclusions: The present study establishes that spot UACR, when measured between 16-20 weeks of gestation in asymptomatic pregnant women, serves as a highly sensitive and specific early screening tool for predicting the subsequent development of preeclampsia.
Metrics
References
Torres-Torres J, Villafan-Bernal JR, Martinez-Portilla RJ, Hidalgo-Carrera JA, Estrada-Gutierrez G, Adalid-Martinez-Cisneros R, et al. Performance of machine-learning approach for prediction of pre-eclampsia in a middle-income country. Ultrasound Obstet Gynecol. 2024;63:350-7. DOI: https://doi.org/10.1002/uog.27510
Dimitriadis E, Rolnik DL, Zhou W, Estrada-Gutierrez G, Koga K, Francisco RPV, et al. Pre-eclampsia. Nat Rev Dis Prim. 2023;9:8. DOI: https://doi.org/10.1038/s41572-023-00417-6
Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020;135:237-60. DOI: https://doi.org/10.1097/AOG.0000000000003891
Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2018;13:291-310. DOI: https://doi.org/10.1016/j.preghy.2018.05.004
Kliman HJ. Uteroplacental blood flow the story of decidualization, menstruation and trophoblast invasion. Am J Pathol. 2011;157:1759-68. DOI: https://doi.org/10.1016/S0002-9440(10)64813-4
Kozer E, Costei AM, Boskovic R. Effects of aspirin consumption during pregnancy on pregnancy outcomes: meta-analysis. Birth Defects Res Part B Dev Reprod Toxicol. 2013;68:70-84. DOI: https://doi.org/10.1002/bdrb.10002
Steegers EA, Von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376(9741): 631-44. DOI: https://doi.org/10.1016/S0140-6736(10)60279-6
Kooffreh ME, Ekott M, Ekpoudom DO. The prevalence of pre-eclampsia among pregnant women in the University of Calabar Teaching Hospital, Calabar. Saudi Journal of Health Sciences. 2014;3(3):133-6. DOI: https://doi.org/10.4103/2278-0521.142317
National Health portal. National Institute of Health and Family Welfare. Pre-eclampsia. Available at: https://www.nhp.gov. in/ disease/ gynaecology-and-obstetrics/ preeclampsia. Accessed on 15 September 2025.
Torres-Torres J, Espino YSS, Villafan-Bernal JR, Orozco-Guzman LE, Solis-Paredes JM, Estrada-Gutierrez G, et al. Effects of maternal characteristics and medical history on first trimester biomarkers for preeclampsia. Front Med. 2023;10:1050923. DOI: https://doi.org/10.3389/fmed.2023.1050923
Magee LA, Nicolaides KH, von Dadelszen P. Preeclampsia. N Engl J Med. 2022;386:1817-32. DOI: https://doi.org/10.1056/NEJMra2109523
Myatt L. The prediction of preeclampsia: The way forward. Am J Obstet Gynecol. 2022;226:1102-7. DOI: https://doi.org/10.1016/j.ajog.2020.10.047
Jung E, Romero R, Yeo L, Gomez-Lopez N, Chaemsaithong P, Jaovisidha A, et al. The etiology of preeclampsia. Am J Obstet Gynecol. 2022;226:844-66. DOI: https://doi.org/10.1016/j.ajog.2021.11.1356
Sogani S, Varma V, Sarkar P. Significance of urinealbumin/creatinineratio (UACR) and uric acid in women with preeclampsia and its comparison with healthy normotensive pregnant women in their third trimester. Acta Medica Lituanica. 2014;21(1):9-15. DOI: https://doi.org/10.6001/actamedica.v21i1.2883
Vestergaard P, Leverett R. Constancy of urinary creatinine excretion. J Lab Clin Med. 1958;51:211-8.
Schab SJ, Christensen RL, Dougherty K, Klahr S. Quantitation of proteinuria by the use of protein to creatinine ratios in single urine samples. Arch Intern Med. 1987;147:943-4. DOI: https://doi.org/10.1001/archinte.1987.00370050135022
Cote AM, Firoz T, Mattman A, Lam EM, Von Dadelszen P, Magee LA. The 24 hour urine collection: gold standard or historical practice? Am J Obst Gynecol. 2008;199(6):625. DOI: https://doi.org/10.1016/j.ajog.2008.06.009
Fagerstrom P, Sallsten G, Akerstrom M, Haraldsson B, Barregard L. Urinary albumin excretion in healthy adults:a cross sectional study of 24 hour versus timed overnight samples and impact of GFR and other personal characteristics. BMC Nephrol. 2015;16:8 DOI: https://doi.org/10.1186/1471-2369-16-8
Huang Q, Gao Y, Yu Y, Wang W, Wang S, Zhong M. Urinary spot albumin: creatinine ratio for documenting proteinuria in women with preeclampsia. Rev Obstet Gynecol. 2012;5(1):9-15.
Agarwal S, Devi P, Gupta R, Verma P, Agarwal A. Evaluation of spot urinary albumin-creatinine ratio as a screening tool in the prediction of preeclampsia. New Ind J Obgyn. 2022;8(2):269-72. DOI: https://doi.org/10.21276/obgyn.2022.8.2.21
Rajeshwari G, Dongare AG, Patil GL, Pujar T. Evaluation of spot urinary albumin - creatinine ratio as a screening tool in the prediction of pre-eclampsia in early pregnancy: a pilot study. Int. J Reprod Contracept Obstet Gynecol. 2020;9:575-9.
Modak R, Das A, Pal A, Ray DK, Pal A. Evaluation of spot urinary protein-creatinine ratio as a predictor of preeclampsia. Int J Clin Obstetr Gynaecol. 2019;3(6):290-3. DOI: https://doi.org/10.33545/gynae.2019.v3.i6e.428
Gupta N, Gupta T, Asthana D. Prediction of preeclampsia in early pregnancy by estimating the spot urinary albumin/creatinine ratio. J Obstet Gynecol Ind. 2017;67(4):258-62. DOI: https://doi.org/10.1007/s13224-016-0958-z
Kedar Sade E, Wainstock T, Tsumi E, Sheiner E. Prenatal Exposure to Preeclampsia and Long-Term Ophthalmic Morbidity of the Offspring. J Clin Med. 2020;9:1271. DOI: https://doi.org/10.3390/jcm9051271
Mooij R, Kapanga RR, Mwampagatwa IH, Mgalega GC, van Dillen J, Stekelenburg J, de Kok BC. Beyond severe acute maternal morbidity: A mixed-methods study on the long-term consequences of (severe pre-)eclampsia in rural Tanzania. Trop Med Int Health. 2021;26:33-44. DOI: https://doi.org/10.1111/tmi.13507
Davidesko S, Nahum Sacks K, Friger M, Haim A, Sheiner E. Prenatal exposure to preeclampsia as a risk factor for long-term endocrine morbidity of the offspring. Hypertens. Pregnancy. 2021;40:21-8. DOI: https://doi.org/10.1080/10641955.2020.1854300
Dongare AG, Patil GL, Pujar T. Evaluation of spot urinary albumin - creatinine ratio as a screening tool in the prediction of pre-eclampsia in early pregnancy: a pilot study. Int J Reproduct Contracept Obstetr Gynecol. 2020;9(2):575-9. DOI: https://doi.org/10.18203/2320-1770.ijrcog20200339
Upadhyay A, Dayal M. Screening for preeclampsia by urine albumin to creatinine ratio. New Ind J Obgyn. 2018;4(2):117-20. DOI: https://doi.org/10.21276/obgyn.2018.4.2.5
Mahajan P, Panda J. Role of spot urine albumin-creatinine ratio in predicting pre-eclampsia between 20-28 weeks of gestation. Ind J Obstetr Gynecol Res. 2021;8(2):162-5. DOI: https://doi.org/10.18231/j.ijogr.2021.035
Devi LT, Nimonkar AR. Spot urinary albumin creatinine ratio as a predictor of preeclampsia and dilemma in clinical interpretation. Int J Reprod Contracept Obstet Gynecol. 2018;7(10):4086-92. DOI: https://doi.org/10.18203/2320-1770.ijrcog20184133
Mishra VV, Goyal PA, Priyankur R, Choudhary S, Aggarwal RS, Gandhi K, et al. Evaluation of spot urinary albumin-creatinine ratio as screening tool in prediction of pre-eclampsia in early pregnancy. J Obstet Gynaecol India. 2017;67(6):405-8. DOI: https://doi.org/10.1007/s13224-016-0950-7
Downloads
Published
How to Cite
Issue
Section
